Empowering Antibiotic Stewardship: Understanding the Use of Procalcitonin

Webinar Description:

This webinar will reinforce better antibiotic use and provide strategies to better utilize the biomarker procalcitonin (PCT) in the most advantageous methods compared to non-specific biomarkers IL-1, IL-6, TNF, leukocytosis, and lactate.  The pathophysiology and kinetics will be reviewed, and applied in case studies to demonstrate best use guidelines. Finally, clinical and financial outcomes will be presented so the attendee can appreciate expected benefits of the application of PCT concepts.

This webinar was originally recorded on 1/16/2020.

Target Audience

Nurses, physician assistants, physicians, emergency responders, physical therapists, patient care assistants, and other healthcare staff

Learning Objectives

At the end of the course, the learner should be able to:

  • Restate the pathophysiology and kinetics of procalcitonin (PCT).
  • Identify current biomarkers used in the management of sepsis in bacterial infection.
  • Describe how PCT can aid in severity assessment and evaluation of therapy choices.
  • Restate the role of PCT in antibiotic stewardship.
  • Describe the expected clinical and health economic outcomes of PCT guided therapy.


Sepsis Alliance gratefully acknowledges the support provided by bioMérieux, Inc. and Merck for this webinar.

    Course summary
    Available credit: 
    • 1.25 Participation
    • 1.70 RN CE Contact Hours
      Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
    Course opens: 
    Course expires: 

    Mike Broyles, PharmD

    Director of Pharmacy and Laboratory Services, St. Bernard's Five Rivers

    Dr. Broyles earned his BSPharm from the University of Missouri, Kansas City, and his PharmD from the University of Arkansas for Medical Sciences, with a primary focus of antibiotic stewardship since 1992. Dr. Broyles has been the Pharmacy Advisory Chairman for Community Health Systems for 18 years, establishing clinical initiatives for the organization. He provides consulting for bioMérieux, Inc., Roche Diagnostics, Abbott Diagnostics, Fujirebio, and ThermoFisher on PCT aided guidance for antibiotic use stewardship programs, as well as for more than 24 IDN’s on stewardship topics. Dr. Broyle has more than nine years’ experience using, researching, and publishing on stewardship and the use of PCT to improve stewardship activities. He has also assisted in development of stewardship software products for pharmacy and hospitals, including: TheraTrac, TheraTrac 2, TheraDoc, Stellara, ICNet, and ABX Alert for antimicrobial stewardship use in hospital ABS programs.

    Sepsis Alliance is approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.7 contact hours.

    Other healthcare providers will receive a certificate of attendance for 1.25 contact hours.

    Medical Disclaimer

    The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

    Available Credit

    • 1.25 Participation
    • 1.70 RN CE Contact Hours
      Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
    Please login or register to take this course.